Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ELR510444 |
Synonyms | |
Therapy Description |
ELR510444 is a small molecule inhibitor of HIF, which may result in apoptosis and has the potential to disrupt the tumor vasculature environment (PMID: 22295124). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ELR510444 | ELR-510444 | ELR510444 is a small molecule inhibitor of HIF, which may result in apoptosis and has the potential to disrupt the tumor vasculature environment (PMID: 22295124). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
VHL loss | renal cell carcinoma | sensitive | ELR510444 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, renal cell carcinoma cells deficient for VHL were sensitive to ELR510444 both in culture and in cell line xenograft models (PMID: 22295124). | 22295124 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|